This is a purely administrative filing adding standard Part III disclosures. No financial restatement, no material event, and no change to the company's financial position. Monitor for the next quarterly filing (10-Q) for any operational updates or guidance changes.
Price Chart
Executive Summary
Genesco filed an amended 10-K/A solely to add Part III information (director biographies, executive compensation, security ownership, and auditor fees) that was omitted from the original 10-K filed March 25, 2026, because the company will not file a proxy statement within 120 days of fiscal year-end. No financial statements were restated, no errors were corrected, and no other items in the original filing were amended. The amendment is purely administrative and contains no new financial data or material corporate events.
Key Facts
- Amendment adds Part III items (director info, executive compensation, beneficial ownership, auditor fees) not included in the original 10-K filed March 25, 2026.
- No financial statements were restated or amended; no error corrections were made.
- New Section 302 certifications by CEO/interim CFO are included; no Section 906 certifications because no financial statements are in this amendment.
- Company will not file a definitive proxy statement within 120 days of fiscal year-end (January 31, 2026).
- Net sales grew 4.8% in Fiscal 2026 with a 6% increase in comparable sales.
- Corporate business unit EVA bonus paid at 51% of target; Journeys Group at 166% of target.
- No PSUs from the Fiscal 2024 grant were earned over the three-year performance period.
- Negative bonus bank balances were canceled at end of Fiscal 2026: CEO Mimi Vaughn ($6.7M), Scott Becker ($1.5M), Parag Desai ($1.7M).
- CFO Cassandra Harris resigned effective March 6, 2026; CEO Mimi Vaughn serves as interim CFO.
- Principal shareholders include Pzena Investment Management (9.9%), Bradley Radoff group (7.9%), BlackRock (7.7%), Dimensional Fund Advisors (6.4%).
Financial Impact
No new financial data in this amendment; original 10-K reported net sales growth of 4.8% and comparable sales growth of 6% for Fiscal 2026.
Risk Factors
- No new risks identified in this administrative amendment.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001193125-26-251478 |
| Document: gco-ex31_2.htm | 0001193125-26-251478 |
| Document: 0001193125-26-251478-index-headers.html | 0001193125-26-251478 |
| Document: 0001193125-26-251478-index.html | 0001193125-26-251478 |
| Document: 0001193125-26-251478.txt | 0001193125-26-251478 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | 8-K | $34.44 $35.12 | ▲ +1.97% | ▲ +3.12% | $34.80 (+1.05%) |
Aug 6, 2026 8w ago | 8-K | $38.49 $35.50 | ▼ −7.77% | ▼ −8.98% | $34.80 (−9.59%) |
Jul 13, 2026 11w ago | DEFA14A | $34.42 $36.97 | ▲ +7.41% | ▲ +8.19% | $34.80 (+1.10%) |
Jun 29, 2026 13w ago | 8-K | $34.80 $33.17 | ▼ −4.68% | ▼ −6.07% | $34.80 (−0.00%) |
Jun 1, 2026 17w ago | 10-K/A | $39.42 $39.69 | ▲ +0.68% | ▲ +3.65% | $34.80 (−11.72%) |
May 29, 2026 18w ago | 8-K | $38.37 $37.93 | ▼ −1.15% | ▲ +1.38% | $34.80 (−9.30%) |
Apr 8, 2026 25w ago | 8-K | $31.57 $34.50 | ▲ +9.28% | ▲ +6.09% | $34.80 (+10.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access